MEG3 and breast cancer: The Kaplan‐Meier analysis also vividly showed that BC patients who were featured by MEG3 methylation or low MEG3 expression were associated with shorter longevity than those with non‐methylated MEG3 or high MEG3 expression (P < .05) (Figure 1E).